Leire Garrido Perez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leire Garrido Perez has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anna Mallach
UK Dementia Research Institute, Imperial College London, UK
1 shared publication - Carola I. Radulescu
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publication - Francesca A. Chaloner
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publication Francesca Osso
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publicationGiada Pedretti
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publicationJoe Airey
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publication
Latest Publications
- Open Access
- 7 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology
Synaptic dysfunction in Alzheimer’s disease (AD) may drive synapse loss and cognitive impairment. Whether AD-related synaptic pathophysiology occurs globally, or in specific synapses, is unclear. We investigate in vivo AD-related synaptic dysfunction during early-stage amyloidosis in App NL-G-F mice. We find reduced presynaptic GABAergic proteins at c-Fos-positive excitatory neurons and increased calcium-mediated activity at excitatory and inhibitory neuronal assemblies. In vivo synaptic structure/function imaging finds reduced density and calcium-mediated activity of GABAergic axonal boutons. Rather than occurring globally, reduced synaptic activity is focused at GABAergic boutons strongly coupled to population activity in the amyloid microenvironment. The selective weakening of population-coupled synaptic activity also occurs in excitatory dendritic spines. Spatial transcriptomics finds parvalbumin-positive inhibitory neurons show differential gene expression associated with downregulated GABAergic synaptic transmission at early stages. We propose that early-stage AD-related synaptic pathophysiology is focused at population-coupled synapses, with molecular measures implicating abnormal synaptic processing as an early-stage feature in parvalbumin-positive interneurons.
- 7 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSelective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology
Synaptic dysfunction in Alzheimer’s disease (AD) may drive synapse loss and cognitive impairment. Whether AD-related synaptic pathophysiology occurs globally, or in specific synapses, is unclear. We investigate in vivo AD-related synaptic dysfunction during early-stage amyloidosis in App NL-G-F mice. We find reduced presynaptic GABAergic proteins at c-Fos-positive excitatory neurons and increased calcium-mediated activity at excitatory and inhibitory neuronal assemblies. In vivo synaptic structure/function imaging finds reduced density and calcium-mediated activity of GABAergic axonal boutons. Rather than occurring globally, reduced synaptic activity is focused at GABAergic boutons strongly coupled to population activity in the amyloid microenvironment. The selective weakening of population-coupled synaptic activity also occurs in excitatory dendritic spines. Spatial transcriptomics finds parvalbumin-positive inhibitory neurons show differential gene expression associated with downregulated GABAergic synaptic transmission at early stages. We propose that early-stage AD-related synaptic pathophysiology is focused at population-coupled synapses, with molecular measures implicating abnormal synaptic processing as an early-stage feature in parvalbumin-positive interneurons.